Stem Cell Reviews and Reports

, Volume 8, Issue 1, pp 91–99

The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good Practice

Authors

    • Newcastle Fertility Centre at LifeNewcastle University
  • Peter Braude
    • Division of Women’s HealthKing’s College London
  • Aidan Courtney
    • Roslin Cells Ltd
  • Daniel Brison
    • NorthWest Embryonic Stem Cell Centre, Central Manchester University Hospitals NHS Trust and the University of ManchesterManchester Academic Health Sciences Centre
  • Charles Hunt
    • UK Stem Cell Bank, Division of Cell Biology and ImagingNational Institute for Biological Standards and Control
  • James Lawford-Davies
    • Newcastle University
    • Lawford Davies Denoon
  • Harry Moore
    • Centre for Stem Cell BiologySheffield University
  • Glyn Stacey
    • UK Stem Cell Bank, Division of Cell Biology and ImagingNational Institute for Biological Standards and Control
  • Sebastian Sethe
    • Newcastle University
    • Lawford Davies Denoon
  • for the Procurement Working Group of the National Clinical hESC Forum
Article

DOI: 10.1007/s12015-011-9288-9

Cite this article as:
Murdoch, A., Braude, P., Courtney, A. et al. Stem Cell Rev and Rep (2012) 8: 91. doi:10.1007/s12015-011-9288-9

Abstract

The donation of human embryos for the derivation of embryonic stem cell lines that may be used in the development of therapeutic products raises more complex ethical, practical and regulatory problems than the donation of embryos for non-clinical research. This review considers these issues and offers recommendations for good practice.

Keywords

Human embryonic stem cellsEmbryo researchEmbryo donationRegulation, Stem cell banksCell therapyStem cell therapyDonor screeningDonor testing

Copyright information

© Springer Science+Business Media, LLC 2011